Hope raised by new medicine, effective on all 37 mutations, know who made it, how does it work?

With the spread of the new variant of Corona, Omicron, to more than 55 countries of the world, the concern of the world has increased. According to the Indian Health Ministry, Omicron has spread to 59 countries including India and so far 2936 cases have been reported worldwide. Also, there are 78,064 cases of Kovid-19 positive that have been kept under investigation considering Omicron suspects. In India too, more than 30 cases of Omicron have been reported. Amidst the growing threat of Omicron, a drug has been created that works on 37 mutations of this new variant.

For the fight against Omicron, the UK company GlaxoSmithKline (GSK) has teamed up with the UK firm Vir Biotechnology to create a monoclonal antibody drug called Sotrovimab.

This drug, called sotrovimab, is sold under the brand name Xevudy. This drug is used in people to prevent the symptoms of covid from becoming severe. Also, it is effective for people with low immunity.Pre-clinical data from last week showed that the monoclonal antibody made from the drug is effective and effective against 37 mutations of Omicron.